These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38305846)

  • 1. Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review.
    Sheppard JP; Benetos A; Bogaerts J; Gnjidic D; McManus RJ
    Curr Hypertens Rep; 2024 May; 26(5):225-236. PubMed ID: 38305846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive Deprescribing in Older Adults: a Practical Guide.
    Sheppard JP; Benetos A; McManus RJ
    Curr Hypertens Rep; 2022 Nov; 24(11):571-580. PubMed ID: 35881225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial.
    Sheppard JP; Burt J; Lown M; Temple E; Lowe R; Fraser R; Allen J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Kodabuckus S; Little P; Mant J; Mollison J; Payne RA; Williams M; Yu LM; McManus RJ;
    JAMA; 2020 May; 323(20):2039-2051. PubMed ID: 32453368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of the evidence for deprescribing interventions among older people living with frailty.
    Ibrahim K; Cox NJ; Stevenson JM; Lim S; Fraser SDS; Roberts HC
    BMC Geriatr; 2021 Apr; 21(1):258. PubMed ID: 33865310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?
    Shantsila E; Lip GYH; Shantsila A; Kurpas D; Beevers G; Gill PS; Williams NH
    J Hypertens; 2023 Oct; 41(10):1502-1510. PubMed ID: 37432893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial.
    Sheppard JP; Temple E; Wang A; Smith A; Pollock S; Ford GA; Hobbs FDR; Kenealy N; Little P; Lown M; de Lusignan S; Mant J; McCartney D; Payne RA; Williams M; Yu LM; McManus RJ;
    Lancet Healthy Longev; 2024 Aug; 5(8):e563-e573. PubMed ID: 39094592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review.
    Ulley J; Harrop D; Ali A; Alton S; Fowler Davis S
    BMC Geriatr; 2019 Jan; 19(1):15. PubMed ID: 30658576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deprescribing in older people.
    Page AT; Potter K; Clifford R; Etherton-Beer C
    Maturitas; 2016 Sep; 91():115-34. PubMed ID: 27451330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New horizons in deprescribing for older people.
    Woodford HJ; Fisher J
    Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial.
    Sheppard JP; Burt J; Lown M; Temple E; Benson J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Little P; Mant J; Mollison J; Nickless A; Ogburn E; Payne R; Williams M; Yu LM; McManus RJ
    BMJ Open; 2018 Oct; 8(9):e022930. PubMed ID: 30287610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing Hypertension Medication in Older Adults: Can It Lower Drug Burden Without Causing Harm?
    Oliveira MG; Moreira PM; Amorim WW; Boockvar K
    Clin Geriatr Med; 2024 Nov; 40(4):659-668. PubMed ID: 39349038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Polypharmacy with Increasing Drug Burden Index Exacerbates Frailty and Impairs Physical Function, with Effects Attenuated by Deprescribing, in Aged Mice.
    Mach J; Gemikonakli G; Logan C; Vander Wyk B; Allore H; Ekambareshwar S; Kane AE; Howlett SE; de Cabo R; Le Couteur DG; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1010-1018. PubMed ID: 32147704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive deprescribing in frail long-term care residents (OptimizeBP): protocol for a prospective, randomised, open-label pragmatic trial.
    Kraut RY; Youngson E; Sadowski CA; Bakal JA; Faulder D; Korownyk CS; Vucenovic A; Eurich DT; Manca DP; Lundby C; Kivi P; Manville M; Garrison SR
    BMJ Open; 2024 Aug; 14(8):e084619. PubMed ID: 39209778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-designing an intervention to improve the process of deprescribing for older people living with frailty in the United Kingdom.
    Silcock J; Marques I; Olaniyan J; Raynor DK; Baxter H; Gray N; Zaidi STR; Peat G; Fylan B; Breen L; Benn J; Alldred DP
    Health Expect; 2023 Feb; 26(1):399-408. PubMed ID: 36420768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials.
    Crisafulli S; Luxi N; Coppini R; Capuano A; Scavone C; Zinzi A; Vecchi S; Onder G; Sultana J; Trifirò G
    BMC Fam Pract; 2021 Oct; 22(1):208. PubMed ID: 34666689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of a protocol for deprescribing antihypertensive medication in older patients in Dutch general practices.
    Hassan D; Versmissen J; Hek K; van Dijk L; van den Bemt PMLA
    BMC Prim Care; 2022 Nov; 23(1):280. PubMed ID: 36352363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of deprescribing for older people with frailty and polypharmacy: part one.
    Lyne S
    Nurs Older People; 2023 Oct; 35(5):35-41. PubMed ID: 37670533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial.
    Jowett S; Kodabuckus S; Ford GA; Hobbs FDR; Lown M; Mant J; Payne R; McManus RJ; Sheppard JP;
    Hypertension; 2022 May; 79(5):1122-1131. PubMed ID: 35266409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.